AWM Investment Company Inc. Makes New $18.15 Million Investment in Sanuwave Health Inc. $SNWV

Key Points

• AWM Investment Company Inc. invested approximately $18.15 million in Sanuwave Health Inc., acquiring 513,230 shares, which represents about 2.5% of their total holdings.
• Sanas Capital Management LLC also purchased a new position in Sanuwave Health valued at $20.66 million during the same quarter, contributing to the 42.53% institutional ownership of the company.
• Analysts have raised their ratings on Sanuwave Health, upgrading it to a "strong-buy" with an average price target of $55.00, reflecting positive sentiment towards the stock's performance.

AWM Investment Company Inc. acquired a new position in shares of Sanuwave Health Inc. (NASDAQ:SNWV - Free Report) during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 513,230 shares of the company's stock, valued at approximately $18,153,000. Sanuwave Health makes up 2.5% of AWM Investment Company Inc.'s holdings, making the stock its 9th biggest holding. AWM Investment Company Inc. owned approximately 6.00% of Sanuwave Health as of its most recent SEC filing.

Separately, Strategic Investment Solutions Inc. IL acquired a new position in Sanuwave Health during the 1st quarter worth $47,000. Institutional investors and hedge funds own 42.53% of the company's stock.

Analyst Ratings Changes

Several brokerages have commented on SNWV. Northland Capmk upgraded shares of Sanuwave Health to a "strong-buy" rating in a research report on Wednesday, September 3rd. Northland Securities assumed coverage on shares of Sanuwave Health in a research report on Wednesday, September 3rd. They set an "outperform" rating and a $55.00 target price for the company. Wall Street Zen cut shares of Sanuwave Health from a "strong-buy" rating to a "buy" rating in a research report on Sunday. Finally, Roth Capital upped their price objective on shares of Sanuwave Health from $54.00 to $55.00 and gave the company a "buy" rating in a research report on Friday, August 22nd. One equities research analyst has rated the stock with a Strong Buy rating and two have issued a Buy rating to the company's stock. Based on data from MarketBeat, the company currently has a consensus rating of "Buy" and a consensus price target of $55.00.

Sanuwave Health Stock Down 2.2%

NASDAQ:SNWV traded down $0.84 during mid-day trading on Monday, reaching $37.04. The stock had a trading volume of 7,509 shares, compared to its average volume of 51,076. The business has a 50-day simple moving average of $37.47. The stock has a market capitalization of $317.43 million, a PE ratio of -4.49 and a beta of 1.39. Sanuwave Health Inc. has a 12 month low of $5.21 and a 12 month high of $46.58.

Sanuwave Health (NASDAQ:SNWV - Get Free Report) last announced its quarterly earnings data on Friday, August 8th. The company reported $0.01 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.09) by $0.10. The firm had revenue of $10.16 million during the quarter, compared to the consensus estimate of $10.14 million. Sanuwave Health has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS.

Sanuwave Health Profile

SANUWAVE Health, Inc, a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, and musculoskeletal and vascular structures.